FrancophonIA/ELRC3.0 huggingface dataset:
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each syringe contains 0.9 mL of solution for injection.
Croatian: Abseamed 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,9 ml otopine za injekciju.
English: INFORMATION IN BRAILLE Abseamed 6,000 IU/0.6 mL
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Abseamed 6000 IU/0,6 ml
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each syringe contains 0.7 mL of solution for injection.
Croatian: Abseamed 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,7 ml otopine za injekciju.
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/412/013
Croatian: Abseamed 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/013
English: INFORMATION IN BRAILLE Abseamed 20,000 IU/0.5 mL
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Abseamed 20 000 IU/0,5 ml
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 9,000 IU/0.9 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 9000 IU/0,9 ml injekcija epoetin alfa i.v./s.c.
English: INFORMATION IN BRAILLE Abseamed 4,000 IU/0.4 mL
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Abseamed 4000 IU/0,4 ml
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each syringe contains 0.4 mL of solution for injection.
Croatian: Abseamed 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,4 ml otopine za injekciju.
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/412/023
Croatian: Abseamed 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/023
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 7,000 IU/0.7 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 7000 IU/0,7 ml injekcija epoetin alfa i.v./s.c.
English: INFORMATION IN BRAILLE Abseamed 5,000 IU/0.5 mL
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Abseamed 5000 IU/0,5 ml
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 30,000 IU/0.75 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 30 000 IU/0,75 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Croatian: Abseamed 1000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 2000 IU epoetina alfa*, što odgovara 16,8 mikrograma po ml.
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Croatian: Abseamed 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 40 000 IU epoetina alfa*, što odgovara 336,0 mikrograma po ml.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 8,000 IU/0.8 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 8000 IU/0,8 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/009
Croatian: Abseamed 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/009
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: Abseamed 30,000 IU/0.75 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Croatian: Abseamed 30 000 IU/0,75 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 40 000 IU epoetina alfa*, što odgovara 336,0 mikrograma po ml.
English: Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each syringe contains 0.6 mL of solution for injection.
Croatian: Abseamed 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,6 ml otopine za injekciju.
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 40,000 IU of epoetin alfa* corresponding to 336.0 micrograms per mL
Croatian: Abseamed 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 40 000 IU epoetina alfa*, što odgovara 336,0 mikrograma po ml.
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Croatian: Abseamed 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 10 000 IU epoetina alfa*, što odgovara 84,0 mikrograma po ml.
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 2,000 IU of epoetin alfa* corresponding to 16.8 micrograms per mL
Croatian: Abseamed 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 2000 IU epoetina alfa*, što odgovara 16,8 mikrograma po ml.
English: INFORMATION IN BRAILLE Abseamed 10,000 IU/1 mL
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Abseamed 10 000 IU/1 ml
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/021
Croatian: Abseamed 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/021
English: INFORMATION IN BRAILLE Abseamed 3,000 IU/0.3 mL
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Abseamed 3000 IU/0,3 ml
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 4,000 IU/0.4 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 4000 IU/0,4 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe EU/1/07/412/019
Croatian: Abseamed 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/019
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 6,000 IU/0.6 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 6000 IU/0,6 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Croatian: Abseamed 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,5 ml otopine za injekciju.
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe EU/1/07/412/011
Croatian: Abseamed 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/011
English: Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Each syringe contains 0.3 mL of solution for injection.
Croatian: Abseamed 3000 IU/0,3 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,3 ml otopine za injekciju.
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe EU/1/07/412/007
Croatian: Abseamed 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/007
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Croatian: Abseamed 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 1 ml otopine za injekciju.
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe EU/1/07/412/017
Croatian: Abseamed 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/017
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/025
Croatian: Abseamed 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/025
English: Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe EU/1/07/412/005
Croatian: Abseamed 3000 IU/0,3 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/005
English: INFORMATION IN BRAILLE Abseamed 2,000 IU/1 mL
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Abseamed 2000 IU/1 ml
English: Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Croatian: Abseamed 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,5 ml otopine za injekciju.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 40,000 IU/1 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 40 000 IU/1 ml injekcija epoetin alfa i.v./s.c.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 5,000 IU/0.5 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 5000 IU/0,5 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 8,000 IU/0.8 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Croatian: Abseamed 8000 IU/0,8 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 10 000 IU epoetina alfa*, što odgovara 84,0 mikrograma po ml.
English: Abseamed 7,000 IU/0.7 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Croatian: Abseamed 7000 IU/0,7 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 10 000 IU epoetina alfa*, što odgovara 84,0 mikrograma po ml.
English: INFORMATION IN BRAILLE Abseamed 1,000 IU/0.5 mL
Croatian: 16. PODACI NA BRAILLEOVOM PISMU Abseamed 1000 IU/0,5 ml
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 3,000 IU/0.3 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 3000 IU/0,3 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 5,000 IU/0.5 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 5000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/015
Croatian: Abseamed 10 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/015
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 20,000 IU/0.5 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 20 000 IU/0,5 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Croatian: Abseamed 10 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 1 ml otopine za injekciju.
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/003
Croatian: Abseamed 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/003
English: Usually the injections will be given to you by a doctor, nurse or other health care professional.
Croatian: medicinska sestra ili drugi zdravstveni radnik.
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe Each syringe contains 1 mL of solution for injection.
Croatian: Abseamed 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 1 ml otopine za injekciju.
English: Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe Each syringe contains 0.5 mL of solution for injection.
Croatian: Abseamed 1000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki Jedna napunjena štrcaljka sadrži 0,5 ml otopine za injekciju.
English: If signs and symptoms suggestive of these reactions appear, Abseamed should be withdrawn immediately and an alternative treatment considered.
Croatian: potrebno je odmah prekinuti primjenu Abseameda i razmisliti o zamjenskom liječenju.
English: Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 3000 IU/0,3 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 1000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 2,000 IU/1 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 2000 IU/1 ml injekcija epoetin alfa i.v./s.c.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 10,000 IU/1 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 10 000 IU/1 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 9,000 IU/0.9 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Croatian: Abseamed 9000 IU/0,9 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 10 000 IU epoetina alfa*, što odgovara 84,0 mikrograma po ml.
English: Abseamed 4,000 IU/0.4 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Croatian: Abseamed 4000 IU/0,4 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 10 000 IU epoetina alfa*, što odgovara 84,0 mikrograma po ml.
English: Abseamed 20,000 IU/0.5 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 20 000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Abseamed 1,000 IU/0.5 mL injection
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA Abseamed 1000 IU/0,5 ml injekcija epoetin alfa i.v./s.c.
English: Abseamed 2,000 IU/1 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 2000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: Abseamed 3,000 IU/0.3 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Croatian: Abseamed 3000 IU/0,3 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 10 000 IU epoetina alfa*, što odgovara 84,0 mikrograma po ml.
English: Abseamed 6,000 IU/0.6 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Croatian: Abseamed 6000 IU/0,6 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 10 000 IU epoetina alfa*, što odgovara 84,0 mikrograma po ml.
English: Abseamed 1,000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/001
Croatian: Abseamed 1000 IU/0,5 ml otopina za injekciju u napunjenoj štrcaljki EU/1/07/412/001
English: Abseamed 40,000 IU/1 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 40 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe Each mL of solution contains 10,000 IU of epoetin alfa* corresponding to 84.0 micrograms per mL
Croatian: Abseamed 10 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki Jedan ml otopine sadrži 10 000 IU epoetina alfa*, što odgovara 84,0 mikrograma po ml.
English: 1 pre-filled syringe of 0.4 mL contains 4,000 international units (IU) corresponding to 33.6 micrograms epoetin alfa.
Croatian: NAVOĐENJE DJELATNE(IH) TVARI 1 napunjena štrcaljka od 0,4 ml sadrži 4000 međunarodnih jedinica (IU) što odgovara 33,6 mikrograma epoetina alfa.
English: Abseamed 10,000 IU/1 mL solution for injection in a pre-filled syringe
Croatian: Abseamed 10 000 IU/1 ml otopina za injekciju u napunjenoj štrcaljki epoetin alfa
English: If the patient has developed a severe cutaneous skin reaction such as SJS or TEN due to the use of Abseamed, treatment with Abseamed must not be restarted in this patient at any time.
Croatian: Johnsonov sindrom ili toksična epidermalna nekroliza, ni u jednom trenutku ne smije se ponovno započeti liječenje tog bolesnika lijekom Abseamed.
English: What is in this leaflet What Abseamed is and what it is used for What you need to know before you use Abseamed How to use Abseamed Possible side effects How to store Abseamed Contents of the pack and other information What Abseamed is and what it is used for Abseamed contains the active substance epoetin alfa, a protein that stimulates the bone marrow to produce more red blood cells which carry haemoglobin (a substance that transports oxygen).
Croatian: Abseamed sadrži djelatnu tvar epoetin alfa, protein koji potiče koštanu srž da proizvodi više crvenih krvnih stanica koje sadrže hemoglobin (tvar koja prenosi kisik).
English: The patients were between 22 months and 72 years old.
Croatian: Bolesnici su bili stari između 22 mjeseca i 72 godine.
English: 1081 CN Amsterdam The Netherlands
Croatian: 1081 CN Amsterdam Nizozemska
English: It is usually given at least every 6 weeks.
Croatian: Obično se daje svakih 6 tjedana.
English: Two of these 8 fatalities occurred within the first 3 years of treatment and 6 of them occurred 8-13 years after treatment.
Croatian: Dva od tih 8 smrtnih slučajeva dogodila su se unutar prve 3 godine liječenja, a 6 od njih dogodilo se 8 do 13 godina nakon liječenja.
English: Emetogenic potential.
Croatian: Emetogeni potencijal.
English: This medicinal product should not be used any further.
Croatian: Ovaj lijek se više ne smije koristiti.
English: If such symptoms occur, you should contact your doctor immediately (see section
Croatian: Ako se takvi simptomi pojave, morate se odmah obratiti svom liječniku (vidjeti dio
English: Lung damage may occur years after treatment.
Croatian: Oštećenje pluća može se dogoditi godinama nakon liječenja.
English: Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu/ema/.
Croatian: Detaljnije informacije o ovom lijeku dostupne su na internetskoj stranici Europske agencije za lijekove: http://www.ema.europa.eu.
English: Harmful for those suffering from alcoholism.
Croatian: Štetno je za ljude koji pate od alkoholizma.
English: As a doctor or nurse will be giving you this medicine, it is unlikely that you will receive an incorrect dose.
Croatian: S obzirom na to da će vam liječnik ili sestra davati ovaj lijek, nije vjerojatno da ćete primiti pogrešnu dozu.
English: On the other hand,
Croatian: Međutim,
English: Percentage of prior dose to be given
Croatian: Postotak prethodne doze koji treba dati
English: Your doctor will talk to you about the possibility of lung damage and allergic reactions and their symptoms.
Croatian: Vaš liječnik razgovarat će s vama o mogućnosti oštećenja pluća i alergijskih reakcija te njihovih simptoma.
English: Carmustine Obvius should not be used during pregnancy because it may harm your unborn baby.
Croatian: Carmustine Obvius ne smije se koristiti tijekom trudnoće jer može naškoditi Vašem nerođenom djetetu.
English: Carmustine Obvius with alcohol
Croatian: Carmustine Obvius s alkoholom
English: Carmustine Obvius may cause the following side effects:
Croatian: Carmustine Obvius može uzrokovati sljedeće nuspojave:
English: The amount of alcohol in this medicine may alter the effects of other medicines.
Croatian: Količina alkohola u ovom lijeku može promijeniti učinke drugih lijekova.
English: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Croatian: Ako ste trudni ili dojite, mislite da biste mogli biti trudni ili planirate imati dijete, obratite se svojem liječniku ili ljekarniku za savjet prije nego primite ovaj lijek.
English: if you are allergic to carmustine or any of the other ingredients of this medicine (listed in section 6).
Croatian: ako ste alergični na karmustin ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.);
English: The following schedule is suggested as a guide to dosage adjustment:
Croatian: Sljedeći raspored predlaže se kao vodič kod prilagodbe doziranja:
English: Long-term follow-up observation of 17 patients who survived brain tumours in childhood showed that 8 of them succumbed to pulmonary fibrosis.
Croatian: Zapažanja iz dugoročnog praćenja 17 bolesnika koji su preživjeli tumore na mozgu u djetinjstvu pokazalo je da je 8 njih podleglo plućnoj fibrozi.
English: All remaining survivors available for follow-up were diagnosed with pulmonary fibrosis.
Croatian: Svim preostalima preživjelima koji su bili dostupni za praćenje dijagnosticirana je plućna fibroza.
English: If you use more Carmustine Obvius than you should
Croatian: Ako primijenite više lijeka Carmustine Obvius nego što ste trebali
English: What Carmustine Obvius is and what it is used for
Croatian: Što je Carmustine Obvius i za što se koristi
English: Other medicines and Carmustine Obvius
Croatian: Drugi lijekovi i Carmustine Obvius
English: Contents of the pack and other information What Carmustine Obvius contains
Croatian: Sadržaj pakiranja i druge informacije Što Carmustine Obvius sadrži
English: The presence of an oily film can be an indication of melting of the medicinal product.
Croatian: Prisutnost masnog filma može biti naznaka otapanja lijeka.
English: The half-life α is 1-4 minutes and the half-life β is 18-69 minutes.
Croatian: 4 minute, a poluvijek β iznosi 18-69 minuta.
English: Safe use in pregnancy has not been established and therefore the benefit must be carefully weighed against the risk of toxicity.
Croatian: Sigurna primjena u trudnoći nije utvrđena i stoga je potrebno pažljivo odmjeriti korist liječenja naspram rizika od toksičnosti.
English: Carmustine Obvius should not be used in children and adolescents due to high risk of pulmonary toxicity.
Croatian: Carmustine Obvius ne smije se koristiti u djece i adolescenata zbog visokog rizika od plućne toksičnosti.
English: Pulmonary toxicity has been observed in up to 30% of patients.
Croatian: Plućna toksičnost uočena je u do 30 % bolesnika.
English: Reconstitution and further dilutions should be carried out under aseptic conditions.
Croatian: Rekonstituciju i daljnja razrjeđenja treba provesti u aseptičkim uvjetima.
English: After the intravenous infusion over 1 hour, the carmustine-plasma level drops in a biphasic manner.
Croatian: Nakon intravenske infuzije u trajanju od sat vremena, plazmatske razine karmustina opadaju na bifazni način.
English: Levels of radioactivity in the cerebrospinal fluid are at least 50% higher than those measured concurrently in plasma.
Croatian: Razine radioaktivnosti u cerebrospinalnoj tekućini su barem 50 % više od onih istodobno izmjerenih u plazmi.
English: The kinetic of carmustine in humans is characterised by a two-chamber model.
Croatian: Kinetika karmustina u ljudi opisana je modelom s dva odjeljka.
English: Because clinical trials are conducted under very specific conditions, the adverse reaction rates observed may not reflect the rates observed in clinical practice.
Croatian: S obzirom na to da se klinička ispitivanja provode pod vrlo specifičnim uvjetima, uočene nuspojave možda neće odražavati stope uočene u kliničkoj praksi.
English: Dosage is based on your medical condition, body size and response to treatment.
Croatian: Doziranje se temelji na vašem zdravstvenom stanju, veličini tijela i reakciji na terapiju.
English: Dosage will also depend on whether Carmustine Obvius is given with other anti-cancer medicines.
Croatian: Doziranje će također ovisiti o tome daje li se Carmustine Obvius s drugim lijekovima protiv raka.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION 10.
Croatian: DATUM PRVOG ODOBRENJA / DATUM OBNOVE ODOBRENJA 10. DATUM REVIZIJE TEKSTA